136 related articles for article (PubMed ID: 17764977)
1. Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [(11)C]diprenorphine test-retest data.
Hammers A; Asselin MC; Turkheimer FE; Hinz R; Osman S; Hotton G; Brooks DJ; Duncan JS; Koepp MJ
Neuroimage; 2007 Oct; 38(1):82-94. PubMed ID: 17764977
[TBL] [Abstract][Full Text] [Related]
2. Quantification of opioid receptor availability following spontaneous epileptic seizures: correction of [11C]diprenorphine PET data for the partial-volume effect.
McGinnity CJ; Shidahara M; Feldmann M; Keihaninejad S; Riaño Barros DA; Gousias IS; Duncan JS; Brooks DJ; Heckemann RA; Turkheimer FE; Hammers A; Koepp MJ
Neuroimage; 2013 Oct; 79():72-80. PubMed ID: 23597934
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
Kim JS; Ichise M; Sangare J; Innis RB
J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
[TBL] [Abstract][Full Text] [Related]
4. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
[TBL] [Abstract][Full Text] [Related]
5. Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.
Riaño Barros DA; McGinnity CJ; Rosso L; Heckemann RA; Howes OD; Brooks DJ; Duncan JS; Turkheimer FE; Koepp MJ; Hammers A
Neuroimage; 2014 Aug; 97():151-62. PubMed ID: 24736184
[TBL] [Abstract][Full Text] [Related]
6. Multi-Scale hierarchical generation of PET parametric maps: application and testing on a [11C]DPN study.
Rizzo G; Turkheimer FE; Keihaninejad S; Bose SK; Hammers A; Bertoldo A
Neuroimage; 2012 Feb; 59(3):2485-93. PubMed ID: 21924366
[TBL] [Abstract][Full Text] [Related]
7. Test-retest reproducibility of quantitative binding measures of [
McGinnity CJ; Riaño Barros DA; Rosso L; Veronese M; Rizzo G; Bertoldo A; Hinz R; Turkheimer FE; Koepp MJ; Hammers A
Neuroimage; 2017 May; 152():270-282. PubMed ID: 28292717
[TBL] [Abstract][Full Text] [Related]
8. 18F-CPFPX PET: on the generation of parametric images and the effect of scan duration.
Meyer PT; Elmenhorst D; Matusch A; Winz O; Zilles K; Bauer A
J Nucl Med; 2006 Feb; 47(2):200-7. PubMed ID: 16455624
[TBL] [Abstract][Full Text] [Related]
9. Parametric Methods for Dynamic
Mansor S; Yaqub M; Boellaard R; Froklage FE; de Vries A; Bakker ED; Voskuyl RA; Eriksson J; Schwarte LA; Verbeek J; Windhorst AD; Lammertsma AA
J Nucl Med; 2017 Mar; 58(3):479-483. PubMed ID: 27660142
[TBL] [Abstract][Full Text] [Related]
10. A consistent and efficient graphical analysis method to improve the quantification of reversible tracer binding in radioligand receptor dynamic PET studies.
Zhou Y; Ye W; Brasić JR; Crabb AH; Hilton J; Wong DF
Neuroimage; 2009 Feb; 44(3):661-70. PubMed ID: 18930830
[TBL] [Abstract][Full Text] [Related]
11. Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.
Salmi E; Aalto S; Hirvonen J; Långsjö JW; Maksimow AT; Oikonen V; Metsähonkala L; Virkkala J; Någren K; Scheinin H
Neuroimage; 2008 Jun; 41(2):260-9. PubMed ID: 18411060
[TBL] [Abstract][Full Text] [Related]
12. Multi-graphical analysis of dynamic PET.
Zhou Y; Ye W; Brasić JR; Wong DF
Neuroimage; 2010 Feb; 49(4):2947-57. PubMed ID: 19931403
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the injected activity in dynamic 3D PET: a generalized approach using patient-specific NECs as demonstrated by a series of 15O-H2O scans.
Walker MD; Matthews JC; Asselin MC; Saleem A; Dickinson C; Charnley N; Julyan PJ; Price PM; Jones T
J Nucl Med; 2009 Sep; 50(9):1409-17. PubMed ID: 19690021
[TBL] [Abstract][Full Text] [Related]
14. Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.
Hume SP; Lingford-Hughes AR; Nataf V; Hirani E; Ahmad R; Davies AN; Nutt DJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):661-7. PubMed ID: 17488881
[TBL] [Abstract][Full Text] [Related]
15. Parametric Net Influx Rate Images of
Ilan E; Sandström M; Velikyan I; Sundin A; Eriksson B; Lubberink M
J Nucl Med; 2017 May; 58(5):744-749. PubMed ID: 27789716
[No Abstract] [Full Text] [Related]
16. Direct reconstruction of kinetic parameter images from dynamic PET data.
Kamasak ME; Bouman CA; Morris ED; Sauer K
IEEE Trans Med Imaging; 2005 May; 24(5):636-50. PubMed ID: 15889551
[TBL] [Abstract][Full Text] [Related]
17. Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.
Talbot PS; Slifstein M; Hwang DR; Huang Y; Scher E; Abi-Dargham A; Laruelle M
Neuroimage; 2012 Jan; 59(1):271-85. PubMed ID: 21782029
[TBL] [Abstract][Full Text] [Related]
18. Parametric mapping of 5HT1A receptor sites in the human brain with the Hypotime method: theory and normal values.
Møller M; Rodell A; Gjedde A
J Nucl Med; 2009 Aug; 50(8):1229-36. PubMed ID: 19617338
[TBL] [Abstract][Full Text] [Related]
19. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data.
Greve DN; Svarer C; Fisher PM; Feng L; Hansen AE; Baare W; Rosen B; Fischl B; Knudsen GM
Neuroimage; 2014 May; 92():225-36. PubMed ID: 24361666
[TBL] [Abstract][Full Text] [Related]
20. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
